Skip to main content
NCBI home page
British Journal of Sports Medicine logoLink to British Journal of Sports Medicine
. 2004 Apr;38(2):129–133. doi: 10.1136/bjsm.2002.000760

Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor

M Piacentini 1, R Meeusen 1, L Buyse 1, G De Schutter 1, K De Meirleir 1
PMCID: PMC1724779  PMID: 15039245

Abstract

Objective: A decrease in dopamine activity is thought to lead to a reduction in motivation and arousal and therefore to the "central" component of fatigue. The purpose of the present study was to investigate the effects of a dopamine (DA) noradrenaline (NA) reuptake inhibitor, bupropion (ZybanTM), on exercise performance and on the hormonal response to exercise.

Methods: Eight healthy well trained male cyclists (Wattmax 397±15 W) participated in the study. Subjects completed one maximal exercise test (to determine maximal power output Wattmax), and two endurance performance tests (time trials) in a double blind randomised cross-over design. Subjects took either placebo capsules (lactose) or 2x300 mg bupropion (BUP). Blood samples were collected for adrenocorticotropin (ACTH), prolactin, cortisol, growth hormone, beta-endorphins, and catecholamines.

Results: Performance was not influenced by BUP (placebo: 89±1 min; BUP 2x300 mg: 89±0.7 min). All hormones increased during exercise in all trials. Cortisol plasma concentrations were significantly higher in the BUP trial at rest, at min 60, and at the end of exercise, while beta-endorphins were higher in the BUP trial at the end of exercise and during recovery, and ACTH at the end of exercise.

Conclusion: From the present results, we can conclude that bupropion had a more marked central noradrenergic effect (compared to dopaminergic) on the hormonal response to exercise, but no effect on the outcome of performance.

Full Text

The Full Text of this article is available as a PDF (285.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acworth I., Nicholass J., Morgan B., Newsholme E. A. Effect of sustained exercise on concentrations of plasma aromatic and branched-chain amino acids and brain amines. Biochem Biophys Res Commun. 1986 May 29;137(1):149–153. doi: 10.1016/0006-291x(86)91188-5. [DOI] [PubMed] [Google Scholar]
  2. Ascher J. A., Cole J. O., Colin J. N., Feighner J. P., Ferris R. M., Fibiger H. C., Golden R. N., Martin P., Potter W. Z., Richelson E. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry. 1995 Sep;56(9):395–401. [PubMed] [Google Scholar]
  3. Bailey S. P., Davis J. M., Ahlborn E. N. Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol Scand. 1992 May;145(1):75–76. doi: 10.1111/j.1748-1716.1992.tb09338.x. [DOI] [PubMed] [Google Scholar]
  4. Blomstrand E., Celsing F., Newsholme E. A. Changes in plasma concentrations of aromatic and branched-chain amino acids during sustained exercise in man and their possible role in fatigue. Acta Physiol Scand. 1988 May;133(1):115–121. doi: 10.1111/j.1748-1716.1988.tb08388.x. [DOI] [PubMed] [Google Scholar]
  5. Chaouloff F., Laude D., Guezennec Y., Elghozi J. L. Motor activity increases tryptophan, 5-hydroxyindoleacetic acid, and homovanillic acid in ventricular cerebrospinal fluid of the conscious rat. J Neurochem. 1986 Apr;46(4):1313–1316. doi: 10.1111/j.1471-4159.1986.tb00656.x. [DOI] [PubMed] [Google Scholar]
  6. Checkley S. A. Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med. 1980 Feb;10(1):35–53. doi: 10.1017/s0033291700039593. [DOI] [PubMed] [Google Scholar]
  7. Cooper B. R., Wang C. M., Cox R. F., Norton R., Shea V., Ferris R. M. Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology. 1994 Oct;11(2):133–141. doi: 10.1038/npp.1994.43. [DOI] [PubMed] [Google Scholar]
  8. Davis J. M., Bailey S. P. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc. 1997 Jan;29(1):45–57. doi: 10.1097/00005768-199701000-00008. [DOI] [PubMed] [Google Scholar]
  9. Gerlo E., Malfait R. High-performance liquid chromatographic assay of free norepinephrine, epinephrine, dopamine, vanillylmandelic acid and homovanillic acid. J Chromatogr. 1985 Sep 13;343(1):9–20. doi: 10.1016/s0378-4347(00)84563-6. [DOI] [PubMed] [Google Scholar]
  10. Laakmann G., Hoffmann N., Hofschuster E. The lack of effect of bupropion HCL (Wellbatrin) on the secretion of growth hormone and prolactin in humans. Life Sci. 1982 May 17;30(20):1725–1732. doi: 10.1016/0024-3205(82)90306-x. [DOI] [PubMed] [Google Scholar]
  11. Meeusen R., De Meirleir K. Exercise and brain neurotransmission. Sports Med. 1995 Sep;20(3):160–188. doi: 10.2165/00007256-199520030-00004. [DOI] [PubMed] [Google Scholar]
  12. Meeusen R., Piacentini M. F., Van Den Eynde S., Magnus L., De Meirleir K. Exercise performance is not influenced by a 5-HT reuptake inhibitor. Int J Sports Med. 2001 Jul;22(5):329–336. doi: 10.1055/s-2001-15648. [DOI] [PubMed] [Google Scholar]
  13. Meeusen R., Roeykens J., Magnus L., Keizer H., De Meirleir K. Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/2C) antagonist. Int J Sports Med. 1997 Nov;18(8):571–577. doi: 10.1055/s-2007-972683. [DOI] [PubMed] [Google Scholar]
  14. Meeusen R., Smolders I., Sarre S., de Meirleir K., Keizer H., Serneels M., Ebinger G., Michotte Y. Endurance training effects on neurotransmitter release in rat striatum: an in vivo microdialysis study. Acta Physiol Scand. 1997 Apr;159(4):335–341. doi: 10.1046/j.1365-201X.1997.00118.x. [DOI] [PubMed] [Google Scholar]
  15. Meeusen R., Thorré K., Chaouloff F., Sarre S., De Meirleir K., Ebinger G., Michotte Y. Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats. Brain Res. 1996 Nov 18;740(1-2):245–252. doi: 10.1016/s0006-8993(96)00872-4. [DOI] [PubMed] [Google Scholar]
  16. Montgomery S. A. Is there a role for a pure noradrenergic drug in the treatment of depression? Eur Neuropsychopharmacol. 1997 Apr;7 (Suppl 1):S3–S73. doi: 10.1016/s0924-977x(97)00414-8. [DOI] [PubMed] [Google Scholar]
  17. Nomikos G. G., Damsma G., Wenkstern D., Fibiger H. C. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology. 1989 Dec;2(4):273–279. doi: 10.1016/0893-133x(89)90031-6. [DOI] [PubMed] [Google Scholar]
  18. Piacentini Maria Francesca, Meeusen Romain, Buyse Luk, De Schutter Guy, Kempenaers Farid, Van Nijvel Joeri, De Meirleir Kenny. No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc. 2002 Jul;34(7):1189–1193. doi: 10.1097/00005768-200207000-00021. [DOI] [PubMed] [Google Scholar]
  19. Strüder H. K., Hollmann W., Platen P., Donike M., Gotzmann A., Weber K. Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm Metab Res. 1998 Apr;30(4):188–194. doi: 10.1055/s-2007-978864. [DOI] [PubMed] [Google Scholar]
  20. Wilson W. M., Maughan R. J. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol. 1992 Nov;77(6):921–924. doi: 10.1113/expphysiol.1992.sp003660. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Sports Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES